T 0195/12 (Deferiprone against cardiac iron overload/APOTEX) of 26.04.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T019512.20170426
- Date of decision
- 26 April 2017
- Case number
- T 0195/12
- Petition for review of
- -
- Application number
- 01949158.8
- IPC class
- A61P 9/00A61K 31/44A61K 31/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- A NEW USE FOR DEFERIPRONE
- Applicant name
- APOTEX INC.
- Opponent name
- Lipomed AG
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 54Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Admission of main request (yes)
Admission of late-filed documents (yes)
Novelty (yes), new group of patients
Remittal (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution on the basis of the claims of the main request filed as auxiliary request 1 together with the statement of grounds of appeal.